Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis.

Vashakidze SA, Kempker JA, Jakobia NA, Gogishvili SG, Nikolaishvili KA, Goginashvili LM, Magee MJ, Kempker RR.

Int J Infect Dis. 2019 Mar 4. pii: S1201-9712(19)30103-1. doi: 10.1016/j.ijid.2019.02.039. [Epub ahead of print]

2.

A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.

Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Little BP, Bernheim A, Derendorf H, Blumberg HM, Vashakidze S, Peloquin CA.

Eur Respir J. 2018 Feb 7;51(2). pii: 1702166. doi: 10.1183/13993003.02166-2017. Print 2018 Feb. No abstract available.

3.

Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study.

Heinrichs MT, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, Bablishvili N, Gogishvili S, Little BP, Bernheim A, Guarner J, Peloquin CA, Blumberg HM, Derendorf H, Kempker RR.

J Antimicrob Chemother. 2018 Feb 1;73(2):477-483. doi: 10.1093/jac/dkx421.

4.

The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.

Rosenthal A, Gabrielian A, Engle E, Hurt DE, Alexandru S, Crudu V, Sergueev E, Kirichenko V, Lapitskii V, Snezhko E, Kovalev V, Astrovko A, Skrahina A, Taaffe J, Harris M, Long A, Wollenberg K, Akhundova I, Ismayilova S, Skrahin A, Mammadbayov E, Gadirova H, Abuzarov R, Seyfaddinova M, Avaliani Z, Strambu I, Zaharia D, Muntean A, Ghita E, Bogdan M, Mindru R, Spinu V, Sora A, Ene C, Vashakidze S, Shubladze N, Nanava U, Tuzikov A, Tartakovsky M.

J Clin Microbiol. 2017 Nov;55(11):3267-3282. doi: 10.1128/JCM.01013-17. Epub 2017 Sep 13.

5.

Reply to Srivastava et al., "pH Conditions under Which Pyrazinamide Works in Humans".

Kempker RR, Peloquin CA, Blumberg HM, Vashakidze S.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01120-17. doi: 10.1128/AAC.01120-17. Print 2017 Sep. No abstract available.

6.

Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.

Kempker RR, Heinrichs MT, Nikolaishvili K, Sabulua I, Bablishvili N, Gogishvili S, Avaliani Z, Tukvadze N, Little B, Bernheim A, Read TD, Guarner J, Derendorf H, Peloquin CA, Blumberg HM, Vashakidze S.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00226-17. doi: 10.1128/AAC.00226-17. Print 2017 Jun.

7.

Development of the food supplement Nyaditum resae as a new tool to reduce the risk of tuberculosis development.

Tukvadze N, Cardona P, Vashakidze S, Shubladze N, Avaliani Z, Vilaplana C, Cardona PJ.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S101-S102. doi: 10.1016/j.ijmyco.2016.09.073. Epub 2016 Nov 14.

8.

Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia.

Vashakidze S, Despuig A, Gogishvili S, Nikolaishvili K, Shubladze N, Avaliani Z, Tukvadze N, Casals M, Caylà JA, Cardona PJ, Vilaplana C.

Int J Infect Dis. 2017 Mar;56:200-207. doi: 10.1016/j.ijid.2016.12.009. Epub 2016 Dec 19. Review.

9.

Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.

Kempker RR, Barth AB, Vashakidze S, Nikolaishvili K, Sabulua I, Tukvadze N, Bablishvili N, Gogishvili S, Singh RS, Guarner J, Derendorf H, Peloquin CA, Blumberg HM.

Antimicrob Agents Chemother. 2015;59(6):3149-55. doi: 10.1128/AAC.00379-15. Epub 2015 Mar 16.

10.

Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.

Lomtadze N, Kupreishvili L, Salakaia A, Vashakidze S, Sharvadze L, Kempker RR, Magee MJ, del Rio C, Blumberg HM.

PLoS One. 2013 Dec 19;8(12):e83892. doi: 10.1371/journal.pone.0083892. eCollection 2013.

11.

Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.

Vashakidze S, Gogishvili S, Nikolaishvili K, Dzidzikashvili N, Tukvadze N, Blumberg HM, Kempker RR.

Ann Thorac Surg. 2013 Jun;95(6):1892-8. doi: 10.1016/j.athoracsur.2013.03.067. Epub 2013 May 1.

12.

Surgical treatment of drug-resistant tuberculosis.

Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM.

Lancet Infect Dis. 2012 Feb;12(2):157-66. doi: 10.1016/S1473-3099(11)70244-4. Review.

13.

Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis.

Kempker RR, Rabin AS, Nikolaishvili K, Kalandadze I, Gogishvili S, Blumberg HM, Vashakidze S.

Clin Infect Dis. 2012 Mar;54(6):e51-4. doi: 10.1093/cid/cir904. Epub 2011 Dec 23.

14.

[Preoperative low energy laser irradiation of the lungs and its effect on prostaglandin and cyclic nucleotide metabolism].

Vashakidze SA, Batiashvili OG, Akopian RL, Ushangishvili MG.

Probl Tuberk. 1994;(4):34-8. Russian. No abstract available.

PMID:
7984613
15.
16.

[Prostaglandins and cyclic nucleotides in patients with surgical intervention in the lungs].

Vashakidze SA, Seperteladze NIa.

Probl Tuberk. 1986;(3):47-51. Russian. No abstract available.

PMID:
3012518

Supplemental Content

Loading ...
Support Center